Evidence map›Paper›PMID 22402756›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2012

Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases.

Rowena C Mercado, Heather Hampel, Fay Kastrinos, Ewout Steyerberg, Judith Balmana, Elena Stoffel, David E Cohn, Floor J Backes, John L Hopper, Mark A Jenkins and 7 more

Abstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Real-World Molecular Testing in European Early-Onset Colorectal Cancer.United European gastroenterology journal · 2025
    Article
  3. Article
  4. Article
  5. A validation of models for prediction of pathogenic variants in mismatch repair genes.Genetics in medicine : official journal of the American College of Medical Genetics · 2022
    Article
  6. Economic Burden of Depression and Associated Resource Use in Manitoba, Canada.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2020
    Article
  7. Effective Identification of Lynch Syndrome in Gastroenterology Practice.Current treatment options in gastroenterology · 2019
    Review
  8. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Development and Validation of the PREMMJournal of clinical oncology : official journal of the American Society of Clinical Oncology · 2017
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Rowena C MercadoPopulation Sciences Division, Dana-Farber Cancer Institute, Boston, MA, USA.
Heather Hampel
Fay Kastrinos
Ewout Steyerberg
Judith Balmana
Elena Stoffel
David E Cohn
Floor J Backes
John L Hopper
Mark A Jenkins
Noralane M Lindor
Graham Casey
Robert Haile
Subha Madhavan
Albert de la Chapelle
Sapna Syngal
Colon Cancer Family Registry

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
USC Consortium:Colorectal Cancer Family RegistryU01CA074799 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAILE, ROBERT WILLIAM · 1997 to 2008
$20.4M
FAMILIAL COLORECTAL NEOPLASIA COLLABORATIVE GROUPU01CA074800 · NCI · MAYO CLINIC ROCHESTER · PI LINDOR, NORALANE MOREY · 1997 to 2007
$9.1M
AUSTRALASIAN COLORECTAL CANCER FAMILY REGISTRYU01CA097735 · NCI · UNIVERSITY OF MELBOURNE · PI HOPPER, JOHN L · 2002 to 2007
$6.9M
Validation and extension of the PREMM Model for mismatch repair gene mutationsR01CA132829 · NCI · DANA-FARBER CANCER INST · PI SYNGAL, SAPNA · 2008 to 2022
$5.6M
INCIDENCE AND MOLECULAR SCREENING FOR HEREDITARY CANCERR01CA067941 · NCI · OHIO STATE UNIVERSITY · PI DE LA CHAPELLE, ALBERT · 2000 to 2004
$2.9M
The Genetics and Prevention of Gastrointestinal CancersK24CA113433 · NCI · DANA-FARBER CANCER INSTITUTE · PI SYNGAL, SAPNA · 2005 to 2014
$1.7M
Assessment of Inherited Colon Cancer Prediction Models in Diverse PopulationsK07CA151769 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KASTRINOS, FAY · 2010 to 2014
$855k
Redox Regulation of Metastasis by Sod2K22CA095011 · NCI · ALBANY MEDICAL COLLEGE · PI MELENDEZ, JUAN ANDRES · 2002 to 2004
$446k
NCI NIH HHS K07 CA151769NCI NIH HHS K24 CA113433NCI NIH HHS P30 CA016058NCI NIH HHS P30 CA16058NCI NIH HHS R01 CA067941NCI NIH HHS R01 CA132829NCI NIH HHS R01CA132829NCI NIH HHS R01 CA67941NCI NIH HHS RFA CA-95-011NCI NIH HHS U01 CA074799NCI NIH HHS U01 CA074800NCI NIH HHS U01 CA097735
6 · The paper itself

Abstract

purposeLynch syndrome accounts for 2-5% of endometrial cancer cases. Lynch syndrome prediction models have not been evaluated among endometrial cancer cases.

methodsArea under the receiver operating curve (AUC), sensitivity and specificity of PREMM(1,2,6), MMRpredict, and MMRpro scores were assessed among 563 population-based and 129 clinic-based endometrial cancer cases.

resultsA total of 14 (3%) population-based and 80 (62%) clinic-based subjects had pathogenic mutations. PREMM(1,2,6), MMRpredict, and MMRpro were able to distinguish mutation carriers from noncarriers (AUC of 0.77, 0.76, and 0.77, respectively), among population-based cases. All three models had lower discrimination for the clinic-based cohort, with AUCs of 0.67, 0.64, and 0.54, respectively. Using a 5% cutoff, sensitivity and specificity were as follows: PREMM(1,2,6), 93% and 5% among population-based cases and 99% and 2% among clinic-based cases; MMRpredict, 71% and 64% for the population-based cohort and 91% and 0% for the clinic-based cohort; and MMRpro, 57% and 85% among population-based cases and 95% and 10% among clinic-based cases.

conclusionCurrently available prediction models have limited clinical utility in determining which patients with endometrial cancer should undergo genetic testing for Lynch syndrome. Immunohistochemical analysis and microsatellite instability testing may be the best currently available tools to screen for Lynch syndrome in endometrial cancer patients.

Indexed as

Genetic TestingAdultAgedArea Under CurveCohort StudiesColorectal Neoplasms, Hereditary NonpolyposisEndometrial NeoplasmsFemaleHumansMiddle AgedModels, StatisticalMutationSensitivity and Specificity

Identifiers

PMID22402756
PMCPMC3396560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.